B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bergenbio ASA
Total Current Liabilities Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Total Current Liabilities
kr43.2m
CAGR 3-Years
-14%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Current Liabilities
kr155.5m
CAGR 3-Years
7%
CAGR 5-Years
12%
CAGR 10-Years
9%
L
Lytix Biopharma AS
OSE:LYTIX
Total Current Liabilities
kr12.5m
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Current Liabilities
kr15.5m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
7%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Current Liabilities
$15.1m
CAGR 3-Years
16%
CAGR 5-Years
60%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Current Liabilities
kr5.2m
CAGR 3-Years
-64%
CAGR 5-Years
-45%
CAGR 10-Years
-3%

See Also

What is Bergenbio ASA's Total Current Liabilities?
Total Current Liabilities
43.2m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Total Current Liabilities amounts to 43.2m NOK.

What is Bergenbio ASA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
5%

Over the last year, the Total Current Liabilities growth was -18%. The average annual Total Current Liabilities growth rates for Bergenbio ASA have been -14% over the past three years , 5% over the past five years .

Back to Top